Comparing Cancer Risk Management Between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants
07:30am - 03:35pm EST - April 5, 2024
07:30am - 03:35pm EST - April 5, 2024
Abstract: JNCCN23-0521 https://jnccn.org/view/journal...
Author(s):
- Diego Garmendia, BA, Undergraduate Student at Vanderbilt University, Vanderbilt-Ingram Cancer Center
Tags: Member Institution Best Practices in Implementation and Use of Clinical Practice Gu
| Display Label | Action |
|---|---|
| 035 - General Poster Session | Download Handout |
| Comparing Cancer Risk Management Between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants_NCCN Poster.pdf | Download Handout |
| AC24P35 - Comparing Cancer Risk Management Between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants | Download MP3 |